SCHEMBL31299861

SCHEMBL31299861

CS(=O)(=O)c1ccc(Nc2ncc3cnn(Cc4cccnc4)c3n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.52
PTGS2 P35354 1/20 0.52
CDK1 P06493 4/20 0.47
CCNB1 P14635 4/20 0.47
CCNT1 O60563 2/20 0.47
CDK9 P50750 2/20 0.47
PTK2 Q05397 5/20 0.46
JAK2 O60674 3/20 0.46
RIPK2 O43353 1/20 0.45
ACVR1 Q04771 1/20 0.45
NOD2 Q9HC29 1/20 0.45
NAMPT P43490 1/20 0.44
FGFR4 P22455 1/20 0.43
AURKA O14965 2/20 0.43
CCNB2 O95067 2/20 0.42
CDK5 Q00535 2/20 0.42
CDK5R1 Q15078 2/20 0.42
CCNB3 Q8WWL7 2/20 0.42
CDK2 P24941 2/20 0.42
CCNE2 O96020 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31299871 0.91 PTGS2 (0.49) PTGS1PTGS2CDK1CCNB1CCNT1
SCHEMBL342369 0.90 CDK1 (0.58) CDK1CCNB1CCNT1CDK9PTK2
SCHEMBL10167381 0.82 NAMPT (0.54) CDK1CCNB1CCNT1CDK9JAK2
SCHEMBL10167393 0.82 EGFR (0.45) CDK1CCNB1CCNT1CDK9PTK2
SCHEMBL15428629 0.81 CDK4 (0.48) CDK1CCNB1CCNT1CDK9PTK2
SCHEMBL10167382 0.80 JAK3 (0.48) PTK2JAK2JAK3
SCHEMBL344496 0.79 CDK4 (0.62) CDK1CCNB1PTK2JAK2FGFR4
SCHEMBL343790 0.79 ABL1 (0.47) PTK2ABL1BCRJAK3NR3C1
SCHEMBL343368 0.78 CDK4 (0.51) PTK2JAK2FGFR4AURKAJAK3
SCHEMBL16570689 0.77 PTK2 (0.52) CDK1CCNB1CCNT1CDK9PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024238570-A1 CDK2 INHIBITOR PYRAZOLOPYRIMIDINE COMPOUNDS ALEKSIA THERAPEUTICS, INC. (US) 2024-11-21 WO disclosed